Achim Aigner Selected Research

Stomach Neoplasms (Stomach Cancer)

5/2024	HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer.
12/2020	SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Achim Aigner Research Topics

Disease

75	Neoplasms (Cancer) 02/2024 - 04/2002
18	Carcinoma (Carcinomatosis) 12/2021 - 08/2002
12	Glioblastoma (Glioblastoma Multiforme) 09/2020 - 04/2002
7	Glioma (Gliomas) 01/2021 - 12/2003
5	Carcinogenesis 02/2021 - 12/2003
5	Neoplasm Metastasis (Metastasis) 11/2020 - 03/2010
4	Melanoma (Melanoma, Malignant) 11/2020 - 06/2013
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2013
3	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 08/2002
3	Brain Neoplasms (Brain Tumor) 01/2022 - 04/2002
3	Adenocarcinoma 06/2021 - 01/2008
2	Stomach Neoplasms (Stomach Cancer) 05/2024 - 12/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2023 - 12/2021
2	Myocardial Infarction 01/2023 - 01/2020
2	Hypercholesterolemia 09/2022 - 04/2014
2	Lung Neoplasms (Lung Cancer) 12/2021 - 01/2008
2	Breast Neoplasms (Breast Cancer) 01/2018 - 02/2005
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2013 - 03/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2013 - 07/2008
1	Thrombocytopenia (Thrombopenia) 08/2023
1	Infarction (Infarctions) 01/2023
1	Disease Progression 01/2023
1	Heart Failure 01/2023
1	Amyloidosis 09/2022
1	Metabolic Diseases (Metabolic Disease) 09/2022
1	Primary hyperoxaluria type 1 09/2022
1	Communicable Diseases (Infectious Diseases) 09/2022
1	Pathologic Processes 07/2022
1	Hemolysis 02/2022
1	Myocarditis (Carditis) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	COVID-19 01/2022
1	Fibrosis (Cirrhosis) 01/2022

Drug/Important Bio-Agent (IBA)

36	Small Interfering RNA (siRNA)IBA 02/2024 - 01/2006
14	Proteins (Proteins, Gene)FDA Link 12/2020 - 08/2002
12	MicroRNAs (MicroRNA)IBA 01/2023 - 05/2011
9	PolyethyleneimineIBA 02/2020 - 07/2006
8	SurvivinIBA 01/2022 - 10/2011
7	Carrier Proteins (Binding Protein)IBA 01/2018 - 08/2002
6	pleiotrophin (HARP)IBA 12/2011 - 04/2002
5	Messenger RNA (mRNA)IBA 02/2013 - 04/2002
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2011 - 04/2002
5	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2011 - 12/2003
4	DNA (Deoxyribonucleic Acid)IBA 04/2023 - 12/2009
4	Transcription Factors (Transcription Factor)IBA 10/2021 - 06/2013
4	Cytostatic AgentsIBA 05/2020 - 05/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2013 - 05/2006
4	Catalytic RNA (Ribozymes)IBA 01/2006 - 04/2002
3	Histone Deacetylase InhibitorsIBA 05/2024 - 07/2019
3	AntigensIBA 04/2022 - 10/2016
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022 - 07/2015
3	CytokinesIBA 01/2022 - 03/2010
3	RNA (Ribonucleic Acid)IBA 09/2020 - 07/2008
3	AntibodiesIBA 05/2020 - 04/2014
3	Phosphotransferases (Kinase)IBA 02/2020 - 04/2002
3	PolymersIBA 12/2013 - 11/2011
3	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 08/2013 - 08/2011
2	Histone Deacetylases (Histone Deacetylase)IBA 05/2024 - 07/2019
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2020
2	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 12/2021
2	LipidsIBA 01/2022 - 04/2014
2	Proteoglycans (Proteoglycan)IBA 12/2021 - 11/2011
2	Nucleic AcidsIBA 12/2021 - 05/2021
2	ChromatinIBA 02/2021 - 12/2020
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021 - 11/2013
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2020 - 04/2002
2	Trastuzumab (Herceptin)FDA Link 05/2020 - 02/2005
2	Cisplatin (Platino)FDA LinkGeneric 05/2020 - 04/2014
2	Caspase 3 (Caspase-3)IBA 02/2020 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2016
2	Therapeutic UsesIBA 10/2019 - 11/2011
2	LectinsIBA 01/2019 - 08/2004
2	CarcinogensIBA 09/2018 - 09/2004
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 05/2011
2	LigandsIBA 01/2017 - 12/2003
2	Keratins (Keratin)IBA 01/2016 - 04/2014
2	Docetaxel (Taxotere)FDA Link 04/2014 - 05/2011
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2011 - 08/2002
2	Anaplastic Lymphoma KinaseIBA 02/2009 - 04/2002
2	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 12/2005 - 12/2003
1	Tyrosine (L-Tyrosine)FDA Link 02/2024
1	Immunoconjugates (Immunoconjugate)IBA 12/2023
1	Cytotoxins (Cytolysins)IBA 12/2023
1	folfirinoxIBA 08/2023
1	AndrogensIBA 01/2023
1	AcetylgalactosamineIBA 09/2022
1	Prealbumin (Transthyretin)IBA 09/2022
1	Acute Hepatic PorphyriaIBA 09/2022
1	Immunoglobulin FragmentsIBA 04/2022
1	poly(ethylenimine sulfide)IBA 02/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	VaccinesIBA 01/2022
1	Carvedilol (Coreg)FDA LinkGeneric 01/2022

Therapy/Procedure

32	Therapeutics 12/2023 - 08/2002
8	Drug Therapy (Chemotherapy) 08/2023 - 08/2004
3	Radiotherapy 09/2020 - 01/2017
2	RNAi Therapeutics 12/2011 - 10/2011
1	Immunotherapy 02/2024
1	Neoadjuvant Therapy 08/2023